Delivery Order SPE2DB22D1200-SPE2DB24FN2EF

Award Date 4/30/24
Potential Completion Date 5/1/24
Potential Value $5.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,787.92, is for the delivery of Imitrex 6 mg/0.5 ml cartridges, a specialty pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed price delivery order with a performance period through March 29, 2024. There was no set-aside designation...
This federal contract award is a delivery order valued at $3,187.05, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imitrex 6 mg/0.5 ml cartridges, a prescription medication used for the treatment of migraines. The contract has a firm fixed price pricing type and an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $16,399.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a medication, with an ultimate completion date of September 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 ml cartridges. The contract has a ceiling value of $21,512.38 and runs through November 19, 2024. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 ml cartridges. The contract has a ceiling value of $1,811.27 and is a firm-fixed-price delivery order with a period of performance through September 16, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded this contract to provide these prescription medication cartridges to support various...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,168.50 delivery order contract is for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Imitrex 6 mg/0.5 ml cartridges (0.5 ml) to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $2,811.21, has a completion date of June 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,747.95 Firm Fixed Price Delivery Order is for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML medical products. The contract has an ultimate completion date of May 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, with an ID of SPE2DB22D3016|SPE2DB24FACQ3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $5,334.55, is for the delivery of Imitrex 6 mg/0.5 ml cartridges. This is a firm-fixed-price delivery order contract with an ultimate completion date of November 8, 2023. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,739.10 firm fixed-price contract is for the supply of Imitrex 6 mg/0.5 ml cartridges, a specialty medication used in the treatment of migraines. The contract is not designated with a set-aside and has an ultimate completion date of November 22, 2024. AmerisourceBergen holds a significant...
  • SPE2DB22D1200
    Indefinite Delivery Contract
  • SPE2DB22D1200-SPE2DB24FN2EF
    Delivery Order

This federal contract award, valued at $5,548.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Imitrex 6 mg/0.5 ml cartridges, a prescription medication. The contract has a May 1, 2024 completion date and was awarded on a firm fixed price basis.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This contract award was not set aside for any specific business category. Amerisourcebergen Drug Corp's Corporate Office Division, as a subsidiary of the Amerisourcebergen Corporation, is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense and Veterans Affairs healthcare systems.

Generated 7/30/24, 9:49 AM